Literature DB >> 2829708

Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus.

E M Swierkosz1, D R Scholl, J L Brown, J D Jollick, C A Gleaves.   

Abstract

A simplified DNA hybridization method was developed to detect acyclovir-resistant isolates of herpes simplex virus. Herpes simplex virus-infected cell cultures in microtiter plates were treated with concentrations of acyclovir ranging from 8 to 0.015 micrograms/ml. At 48 h postinfection, infected cells were lysed by a one-step procedure and lysates were absorbed to membranes. Without further treatment, membranes were hybridized by using a herpes simplex virus-specific radioiodinated probe. The membranes were then washed and counted in a gamma counter. The elapsed time for assay performance was 4 h. Parallel plaque reduction assays were performed for comparison. The mean 50% inhibitory dose of in vivo- and in vitro-derived acyclovir-resistant, thymidine kinase-negative isolates was greater than 2 micrograms/ml by DNA hybridization. The 50% inhibitory dose of acyclovir-susceptible, thymidine kinase-positive isolates ranged from 0.01 to 1.1 micrograms/ml. This assay is simple and objective and should facilitate antiviral susceptibility testing in diagnostic laboratories.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2829708      PMCID: PMC174972          DOI: 10.1128/AAC.31.10.1465

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Problems associated with the use of (E)-5-(2-bromovinyl)-2'-deoxyuridine for typing herpes simplex virus.

Authors:  E M Swierkosz; M Q Arens; K A Rivetna
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

2.  Identification of small DNA fragments synthesized in herpes simplex virus-infected cells in the presence of acyclovir.

Authors:  P V McGuirt; J E Shaw; G B Elion; P A Furman
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

3.  A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents.

Authors:  C McLaren; M N Ellis; G A Hunter
Journal:  Antiviral Res       Date:  1983-11       Impact factor: 5.970

4.  Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir.

Authors:  J C Wade; C McLaren; J D Meyers
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

5.  Simplified method for typing herpes simplex virus by restriction endonuclease analysis.

Authors:  M Q Arens; E M Swierkosz
Journal:  J Clin Microbiol       Date:  1983-03       Impact factor: 5.948

6.  Thymidine plaque autoradiography of thymidine kinase-positive and thymidine kinase-negative herpesviruses.

Authors:  R B Tenser; J C Jones; S J Ressel; F A Fralish
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

7.  Acyclovir triphosphate is a suicide inactivator of the herpes simplex virus DNA polymerase.

Authors:  P A Furman; M H St Clair; T Spector
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

8.  Phosphorylation of acyclovir diphosphate by cellular enzymes.

Authors:  W H Miller; R L Miller
Journal:  Biochem Pharmacol       Date:  1982-12-01       Impact factor: 5.858

9.  Nucleic acid hybridization, a method to determine effects of antiviral compounds on herpes simplex virus type 1 DNA synthesis.

Authors:  H Gadler; A Larsson; E Sølver
Journal:  Antiviral Res       Date:  1984-04       Impact factor: 5.970

Review 10.  Interim summary of mortality in herpes simplex encephalitis and neonatal herpes simplex virus infections: vidarabine versus acyclovir.

Authors:  R J Whitley
Journal:  J Antimicrob Chemother       Date:  1983-09       Impact factor: 5.790

View more
  14 in total

1.  Use of a single monoclonal antibody to determine the susceptibilities of herpes simplex virus type 1 and type 2 clinical isolates to acyclovir.

Authors:  Christine Chutkowski; Betty Olson; Ann McDonough; James Mahoney; James J McSharry
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Detection of herpes simplex virus by a nonradiometric spin-amplified in situ hybridization assay.

Authors:  M S Forman; C S Merz; P Charache
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

Review 3.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

4.  Comparative evaluation of microplate enzyme-linked immunosorbent assay versus plaque reduction assay for antiviral susceptibility testing of herpes simplex virus isolates.

Authors:  S Safrin; E Palacios; B J Leahy
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

5.  Antiviral susceptibility testing with a cell line which expresses beta-galactosidase after infection with herpes simplex virus.

Authors:  P Tebas; E C Stabell; P D Olivo
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

6.  Clinical application of novel sample processing technology for the identification of salmonellae by using DNA probes.

Authors:  D R Scholl; C Kaufmann; J D Jollick; C K York; G R Goodrum; P Charache
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

7.  A rapid phenotypic assay for detection of acyclovir-resistant varicella-zoster virus with mutations in the thymidine kinase open reading frame.

Authors:  R Sahli; G Andrei; C Estrade; R Snoeck; P R Meylan
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

Review 8.  Persistent herpes simplex virus infection and mechanisms of virus drug resistance.

Authors:  H J Field
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-08       Impact factor: 3.267

9.  Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis.

Authors:  G Boivin; A Erice; D D Crane; D L Dunn; H H Balfour
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

10.  Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.

Authors:  C Danve-Szatanek; M Aymard; D Thouvenot; F Morfin; G Agius; I Bertin; S Billaudel; B Chanzy; M Coste-Burel; L Finkielsztejn; H Fleury; T Hadou; C Henquell; H Lafeuille; M E Lafon; A Le Faou; M C Legrand; L Maille; C Mengelle; P Morand; F Morinet; E Nicand; S Omar; B Picard; B Pozzetto; J Puel; D Raoult; C Scieux; M Segondy; J M Seigneurin; R Teyssou; C Zandotti
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.